EdgarLookup

KITE REALTY GROUP TRUST — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that KITE REALTY GROUP TRUST filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
35.4%
Profit Margin
Net income ÷ revenue
4.5%
Return on Assets
Net income ÷ assets
1.13x
Debt-to-Equity
Total liabilities ÷ equity
+0.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $844.37M Feb 17, 2026
FY2025 Dec 31, 2024 $837.48M Feb 17, 2026
FY2025 Dec 31, 2023 $821.34M Feb 17, 2026
FY2024 Dec 31, 2022 $802.00M Feb 12, 2025
FY2023 Dec 31, 2021 $373.32M Feb 20, 2024
FY2022 Dec 31, 2020 $266.65M Feb 21, 2023
FY2019 Dec 31, 2019 $75.27M Feb 20, 2020
FY2019 Sep 30, 2019 $74.94M Feb 20, 2020
FY2019 Jun 30, 2019 $81.48M Feb 20, 2020
FY2019 Mar 31, 2019 $83.52M Feb 20, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $298.66M Feb 17, 2026
FY2025 Dec 31, 2024 $4.07M Feb 17, 2026
FY2025 Dec 31, 2023 $47.50M Feb 17, 2026
FY2024 Dec 31, 2022 ($12.64M) Feb 12, 2025
FY2023 Dec 31, 2021 ($80.81M) Feb 20, 2024
FY2022 Dec 31, 2020 ($16.22M) Feb 21, 2023
FY2021 Dec 31, 2019 ($534.0K) Feb 28, 2022
FY2020 Dec 31, 2018 ($46.57M) Feb 22, 2021
FY2019 Dec 31, 2017 $11.87M Feb 20, 2020
FY2018 Dec 31, 2016 $1.18M Feb 27, 2019

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $111.39M Feb 12, 2025
FY2024 Dec 31, 2023 $152.24M Feb 12, 2025
FY2024 Dec 31, 2022 $91.67M Feb 12, 2025
FY2023 Dec 31, 2021 ($21.52M) Feb 20, 2024
FY2022 Dec 31, 2020 $35.01M Feb 21, 2023
FY2019 Dec 31, 2019 $30.19M Feb 20, 2020
FY2019 Sep 30, 2019 $1.32M Feb 20, 2020
FY2019 Jun 30, 2019 $17.32M Feb 20, 2020
FY2019 Mar 31, 2019 $22.98M Feb 20, 2020
FY2019 Dec 31, 2018 ($13.76M) Feb 20, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $429.66M Feb 17, 2026
FY2025 Dec 31, 2024 $419.03M Feb 17, 2026
FY2025 Dec 31, 2023 $394.65M Feb 17, 2026
FY2024 Dec 31, 2022 $379.28M Feb 12, 2025
FY2023 Dec 31, 2021 $100.35M Feb 20, 2024
FY2022 Dec 31, 2020 $95.52M Feb 21, 2023
FY2021 Dec 31, 2019 $137.96M Feb 28, 2022
FY2020 Dec 31, 2018 $154.38M Feb 22, 2021
FY2019 Dec 31, 2017 $154.62M Feb 20, 2020
FY2018 Dec 31, 2016 $155.36M Feb 27, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2019 Dec 31, 2019 $53.28M Feb 20, 2020
FY2019 Dec 31, 2018 $59.30M Feb 20, 2020
FY2019 Dec 31, 2017 $72.43M Feb 20, 2020
FY2018 Dec 31, 2016 $94.61M Feb 27, 2019
FY2017 Dec 31, 2015 $92.56M Feb 20, 2018
FY2016 Dec 31, 2014 $94.55M Feb 27, 2017
FY2015 Dec 31, 2013 $112.58M Feb 26, 2016
FY2014 Dec 31, 2012 $114.15M Feb 27, 2015
FY2013 Dec 31, 2011 $63.56M Mar 7, 2014
FY2012 Dec 31, 2010 $39.03M Mar 8, 2013

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.66B Feb 17, 2026
FY2025 Dec 31, 2024 $7.09B Feb 17, 2026
FY2024 Dec 31, 2023 $6.94B Feb 12, 2025
FY2023 Dec 31, 2022 $7.34B Feb 20, 2024
FY2022 Dec 31, 2021 $7.64B Feb 21, 2023
FY2021 Dec 31, 2020 $2.61B Feb 28, 2022
FY2020 Dec 31, 2019 $2.65B Feb 22, 2021
FY2019 Dec 31, 2018 $3.17B Feb 20, 2020
FY2018 Dec 31, 2017 $3.51B Feb 27, 2019
FY2017 Dec 31, 2016 $3.66B Feb 20, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.47B Feb 17, 2026
FY2025 Dec 31, 2024 $3.68B Feb 17, 2026
FY2024 Dec 31, 2023 $3.30B Feb 12, 2025
FY2023 Dec 31, 2022 $3.52B Feb 20, 2024
FY2022 Dec 31, 2021 $3.66B Feb 21, 2023
FY2021 Dec 31, 2020 $1.33B Feb 28, 2022
FY2020 Dec 31, 2019 $1.31B Feb 22, 2021
FY2019 Dec 31, 2018 $1.71B Feb 20, 2020
FY2018 Dec 31, 2017 $1.87B Feb 27, 2019
FY2017 Dec 31, 2016 $1.92B Feb 20, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.07B Feb 17, 2026
FY2025 Dec 31, 2024 $3.31B Feb 17, 2026
FY2025 Dec 31, 2023 $3.57B Feb 17, 2026
FY2025 Dec 31, 2022 $3.77B Feb 17, 2026
FY2024 Dec 31, 2021 $3.92B Feb 12, 2025
FY2023 Dec 31, 2020 $1.23B Feb 20, 2024
FY2022 Dec 31, 2019 $1.29B Feb 21, 2023
FY2021 Dec 31, 2018 $1.41B Feb 28, 2022
FY2020 Dec 31, 2017 $1.57B Feb 22, 2021
FY2019 Dec 31, 2016 $1.64B Feb 20, 2020

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.56B) Feb 17, 2026
FY2025 Dec 31, 2024 ($1.60B) Feb 17, 2026
FY2024 Dec 31, 2023 ($1.37B) Feb 12, 2025
FY2023 Dec 31, 2022 ($1.21B) Feb 20, 2024
FY2022 Dec 31, 2021 ($962.91M) Feb 21, 2023
FY2021 Dec 31, 2020 ($824.31M) Feb 28, 2022
FY2020 Dec 31, 2019 ($769.96M) Feb 22, 2021
FY2019 Dec 31, 2018 ($662.74M) Feb 20, 2020
FY2018 Dec 31, 2017 ($509.83M) Feb 27, 2019
FY2017 Dec 31, 2016 ($419.31M) Feb 20, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $36.76M Feb 17, 2026
FY2025 Dec 31, 2024 $128.06M Feb 17, 2026
FY2025 Dec 31, 2023 $36.41M Feb 17, 2026
FY2024 Dec 31, 2022 $115.80M Feb 12, 2025
FY2023 Dec 31, 2021 $93.24M Feb 20, 2024
FY2022 Dec 31, 2020 $43.65M Feb 21, 2023
FY2021 Dec 31, 2019 $31.34M Feb 28, 2022
FY2020 Dec 31, 2018 $35.38M Feb 22, 2021
FY2019 Dec 31, 2017 $24.08M Feb 20, 2020
FY2018 Dec 31, 2016 $19.88M Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.03B Feb 17, 2026
FY2025 Dec 31, 2024 $3.23B Feb 17, 2026
FY2024 Dec 31, 2023 $2.83B Feb 12, 2025
FY2023 Dec 31, 2022 $3.01B Feb 20, 2024
FY2022 Dec 31, 2021 $3.15B Feb 21, 2023
FY2021 Dec 31, 2020 $1.17B Feb 28, 2022
FY2020 Dec 31, 2019 $1.15B Feb 22, 2021
FY2019 Dec 31, 2018 $1.54B Feb 20, 2020
FY2018 Dec 31, 2017 $1.70B Feb 27, 2019
FY2017 Dec 31, 2016 $1.73B Feb 20, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 17, 2026
FY2025 Dec 31, 2024 0 Feb 17, 2026
FY2025 Dec 31, 2023 0 Feb 17, 2026
FY2024 Dec 31, 2022 0 Feb 12, 2025
FY2023 Dec 31, 2021 0 Feb 20, 2024
FY2022 Dec 31, 2020 0 Feb 21, 2023
FY2021 Dec 31, 2019 0 Feb 28, 2022
FY2019 Dec 31, 2018 0 Feb 20, 2020
FY2019 Dec 31, 2017 0 Feb 20, 2020
FY2018 Dec 31, 2016 0 Feb 27, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 17, 2026
FY2025 Dec 31, 2024 0 Feb 17, 2026
FY2025 Dec 31, 2023 0 Feb 17, 2026
FY2024 Dec 31, 2022 0 Feb 12, 2025
FY2023 Dec 31, 2021 0 Feb 20, 2024
FY2022 Dec 31, 2020 0 Feb 21, 2023
FY2021 Dec 31, 2019 0 Feb 28, 2022
FY2019 Dec 31, 2018 0 Feb 20, 2020
FY2017 Dec 31, 2017 0 Feb 20, 2018
FY2017 Sep 30, 2017 0 Feb 20, 2018

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 208.98M Feb 17, 2026
FY2025 Dec 31, 2024 219.67M Feb 17, 2026
FY2024 Dec 31, 2023 219.45M Feb 12, 2025
FY2023 Dec 31, 2022 219.19M Feb 20, 2024
FY2022 Dec 31, 2021 218.95M Feb 21, 2023
FY2021 Dec 31, 2020 84.19M Feb 28, 2022
FY2020 Dec 31, 2019 83.96M Feb 22, 2021
FY2019 Dec 31, 2018 83.80M Feb 20, 2020
FY2018 Dec 31, 2017 83.61M Feb 27, 2019
FY2017 Dec 31, 2016 83.55M Feb 20, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $236.48M Feb 17, 2026
FY2025 Dec 31, 2024 $221.79M Feb 17, 2026
FY2025 Dec 31, 2023 $210.55M Feb 17, 2026
FY2024 Dec 31, 2022 $179.62M Feb 12, 2025
FY2023 Dec 31, 2021 $57.80M Feb 20, 2024
FY2022 Dec 31, 2020 $38.13M Feb 21, 2023
FY2021 Dec 31, 2019 $133.26M Feb 28, 2022
FY2020 Dec 31, 2018 $106.32M Feb 22, 2021
FY2019 Dec 31, 2017 $101.13M Feb 20, 2020
FY2018 Dec 31, 2016 $94.67M Feb 27, 2019